Wall Street's major averages ended lower on Friday, with the S&P 500 (SP500) and the Nasdaq (COMP:IND) ending the week in the ...

Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you ...

Dow Jones Top Company Headlines at 7 PM ET: JPMorgan Stock Sinks on Higher Expense Outlook. Other Banks May Have to Keep Up. | Nvidia ... JPMorgan Stock Sinks on Higher Expense Outlook. Other Banks ...

The executive, who would expand the size of the board to a total of 11 members, will stand election at the media giant's 2026 ...

Health-care companies fell as traders weighed risks in a wave of deal activity. Pfizer joined Big Pharma rivals hunting for novel weight loss drugs in the Chinese biotech sector.

Jeff Williams, a former Apple executive, will stand for election as a new independent director of Disney at the 2026 annual ...

Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable ...

A record-setting Mega Millions ticket worth more than $5.1 million was sold in California this week, marking one of the ...

Hospital systems Steward Health Care and Prospect Medical Holdings, among the largest tenants of healthcare real estate owner Medical Properties Trust, have brought on financial advisers to help ...

The Florida Gators have a new football coach but that coach, Jon Sumrall, is still coaching Tulane, which plays North Texas Friday night.

People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.

The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and Astellas Pharma Inc. that will face a 48% discount off its 2024 list price. GSK ...